A carregar...
Vitamin C sensitizes triple negative breast cancer to PI3K inhibition therapy
Rationale: The clinical use of PI3K inhibitors, such as buparlisib, has been plagued with toxicity at effective doses. The aim of this study is to determine if vitamin C, a potent epigenetic regulator, can improve the therapeutic outcome and reduce the dose of buparlisib in treating PIK3CA-mutated t...
Na minha lista:
| Publicado no: | Theranostics |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ivyspring International Publisher
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7914363/ https://ncbi.nlm.nih.gov/pubmed/33664847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.53225 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|